A tariff on imported steel can protect a steel producer while making an American machinery manufacturer less competitive. A tariff on semiconductor products can raise the cost of equipment assembled in the United States. A tariff on pharmaceutical ingredients can burden domestic drug production. These are not peripheral complications. They are central to understanding why the expanding American tariff regime risks damaging the economy it is supposed to strengthen. Protection for one industry becomes a cost imposed on another, and the same business can find itself benefiting from one measure while struggling under several others. Somewhere between the political announcement and the factory invoice, the promise of national renewal becomes a rather ordinary increase in operating costs.
The Congressional Research Service’s “Active Presidential Tariff Actions in 2026: Fact Sheet,” published October 8, provides a useful view of this expanding system. Its snapshot is current as of September 30, an important distinction when trade policy changes faster than companies can revise their purchasing plans. The report maps measures and investigations involving metals, automobiles, pharmaceuticals, semiconductors, drones, industrial machinery and other sectors. It distinguishes duties already imposed from investigations and negotiated arrangements, which should not be lumped together as if every proposed restriction were already in force. Nevertheless, the breadth of the map reveals the larger problem: tariffs are becoming a pervasive instrument for directing industrial activity, with consequences reaching well beyond the businesses nominally being protected.
The first economic weakness is straightforward. U.S. importers pay U.S. tariffs. Foreign suppliers may absorb some of the burden through lower prices, and exchange-rate movements can change how costs are distributed, but there is no dependable mechanism that makes the foreign country pick up the entire bill. American companies must decide whether to accept lower margins, raise prices, change suppliers or reduce purchases. Their customers then face similar choices. A manufacturer buying imported components may pass higher costs to a distributor, who passes them to a retailer, who passes them to the household. Alternatively, the manufacturer absorbs the cost and has less money available for wages, equipment or expansion. Neither outcome resembles a free economic victory.
This becomes particularly damaging when the taxed imports are inputs into American production. Steel, copper, semiconductor products and vehicle parts are embedded in the things domestic companies manufacture, install and maintain. Making these inputs more expensive can weaken the very industrial base that tariff policy claims to rebuild. A protected supplier may gain pricing power, while a much wider group of downstream businesses loses competitiveness. Exporters face an especially awkward position: they can pay higher input costs at home while competing overseas against producers that do not carry the same burden. The relevant question is therefore whether any gains in the protected industry outweigh the losses across the businesses and customers that depend on it. Counting only the beneficiaries produces a flattering answer by leaving much of the economy out of the calculation.
Overlapping measures make this problem harder to manage. The CRS fact sheet describes a system operating through several legal authorities, with sector-specific actions, country differences, exemptions and ongoing investigations. A company cannot safely plan around a single headline tariff rate. It must examine which goods are covered, where they originate, whether an exemption applies and whether additional duties affect the transaction. Where measures accumulate, the consequences can become severe; where exceptions soften them, compliance still consumes time and money. Large corporations can employ customs specialists and negotiate alternative sourcing arrangements. Smaller manufacturers often have fewer options. For them, complexity itself becomes a competitive disadvantage, quite apart from the duty on the invoice.
Uncertainty adds another cost that does not appear neatly in tariff revenue figures. A production line requires commitments that last years. Trade measures can change much sooner. A business considering a U.S. factory needs confidence about the future cost of machinery, components and raw materials, as well as access to export markets. Tariffs might encourage domestic production of a particular product, but a broader tariff regime can simultaneously make building and operating the factory more expensive. If management cannot establish which effect will dominate, postponement becomes a rational response. Policy intended to accelerate investment can instead encourage companies to preserve cash and wait. That is a poor foundation for an industrial revival.
The argument for domestic capacity deserves serious consideration. Dependence on a narrow set of overseas suppliers can create real vulnerabilities, especially in defense and critical infrastructure. But identifying a vulnerability does not establish that a broad tariff is the most effective remedy. A credible industrial strategy needs reliable procurement, skilled workers, adequate infrastructure, research capacity and a practical route to competitive production. Tariffs can shelter a producer from foreign competition without solving any of those problems. Unless protection is connected to measurable improvements, it can become a recurring subsidy paid through higher prices, allowing weak productivity to persist behind a political barrier.
Pharmaceuticals illustrate why the distinction matters. Increasing domestic manufacturing capacity may improve resilience, but raising the cost of imported medicines or ingredients before sufficient alternatives exist can impose an immediate burden without delivering an immediate supply benefit. Semiconductors present a related challenge: chip production depends on an international network of equipment, materials, design capabilities and specialized suppliers. Restricting parts of that network does not automatically recreate it inside the United States. Industrial ecosystems take time to develop. A tariff can arrive at customs tomorrow; a competitive replacement supply chain usually cannot.
There is also a less visible effect on domestic competition. Import restrictions can give American suppliers room to raise prices even when their own costs have not increased by the full amount of the tariff. Customers lose alternatives, and protected producers face less pressure to improve efficiency. Some firms will use that breathing space to invest. Others may simply enjoy it. Policymakers should not assume that higher producer margins inevitably translate into better technology, more capacity or lower future prices. Those outcomes require evidence, especially when the public is being asked to finance the experiment through more expensive goods.
The CRS tariff map does not, by itself, calculate the net economic damage of every measure. It does show how widely trade restrictions now reach into industrial decision-making. The economic criticism follows from that breadth: when protection expands across interconnected sectors, it increasingly taxes American production alongside American consumption. The administration can point to individual factories, favored industries or customs receipts, but the test is broader—whether the economy produces more competitively, invests more confidently and delivers greater purchasing power. An industrial policy that raises input costs, complicates sourcing and makes long-term commitments harder is working against those objectives. America needs stronger productive capacity. Making it more expensive to produce in America is an unconvincing way to get there.
